Announcing a New Webinar Series on Mineralocorticoid Receptor Antagonists (MRAs) and Diabetic Kidney Disease (DKD) Management
Connect to the first webinar on September 7, 2021, from 3 - 4.15 p. m. CEST Register here. Prevention and treatment of DKD are critical to the future of global kidney health. Previously, the use of MRA in DKD has been limited by its adverse side effects. The development of non-steroidal MRAs seeks to optimize DKD treatment...